Key facts
- This page summarizes Michael Klayko's Form 4 filing for ALLSCRIPTS HEALTHCARE SOLUTIONS, INC. (MDRX).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 09 Jun 2021, 16:30.
Michael Klayko - 08 Jun 2021 Form 4 Insider Report for ALLSCRIPTS HEALTHCARE SOLUTIONS, INC. (MDRX)
- Reporting relationship
- Director
- Issuer ticker
- MDRX
- Reported as of
- 08 Jun 2021
- Net transaction value
- -$504,952
- SEC form
- 4
- Accepted by SEC
- 09 Jun 2021, 16:30:26 UTC
- Prior SEC filing
- 04 Jun 2021
- Source filing
- View source filing
- Reporting owner signature
- Holly O'Berry by power of attorney for Michael Klayko
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Michael Klayko filed Form 4 for ALLSCRIPTS HEALTHCARE SOLUTIONS, INC. (MDRX) on 09 Jun 2021.
Change
- Previous filing in this sequence was filed on 04 Jun 2021.
- Current net transaction value: -$504,952.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MDRX
transaction
Common Stock
Sale
- Transaction value
- $504,952
- Shares
- -28,000
- Change %
- -42%
- Price
- $18.03
- Shares after
- 38,581
- Date
- 08 Jun 2021
- Ownership
- Direct
- Footnotes
- F1
MDRX
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 5,000
- Date
- 08 Jun 2021
- Ownership
- Family Trust
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
These transactions were executed in multiple trades at prices ranging from $17.985 to $18.085. The prices reported reflect the weighted average sale price on the transaction date. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.